G069-0002 Screening compound: 5-{[3-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-yl)-3-oxopropyl]sulfonyl}-1-methyl-1,3-dihydro-2H-indol-2-one

G069-0002 Screening compound: 5-{[3-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-yl)-3-oxopropyl]sulfonyl}-1-methyl-1,3-dihydro-2H-indol-2-one
G069-0002 Screening compound: 5-{[3-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-yl)-3-oxopropyl]sulfonyl}-1-methyl-1,3-dihydro-2H-indol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G069-0002
5-{[3-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-yl)-3-oxopropyl]sulfonyl}-1-methyl-1,3-dihydro-2H-indol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G069-0002

Molecular Formula

C21H20N4O4S (C21 H20 N4 O4 S)

Compound Name

5-{[3-(2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-1-yl)-3-oxopropyl]sulfonyl}-1-methyl-1,3-dihydro-2H-indol-2-one

IUPAC name

1-methyl-5-(3-oxo-3-{257-triazatricyclo[6.4.0.0^{26}]dodeca-1(8)6911-tetraen-5-yl}propanesulfonyl)-23-dihydro-1H-indol-2-one

SMILES

CN(C(C1)=O)c(cc2)c1cc2S(CCC(N1c2nc(cccc3)c3n2CC1)=O)(=O)=O

InChI

InChI=1S/C21H20N4O4S/c1-23-17-7-6-15(12-14(17)13-20(23)27)30(28,29)11-8-19(26)25-10-9-24-18-5-3-2-4-16(18)22-21(24)25/h2-7,12H,8-11,13H2,1H3

InChI Key

LCQUMSNOVQQHSB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14978287

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.48

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.761

Distribution Coefficient, logD

1.431

Water Solubility, LogSw

-2.52

Polar Surface Area

70.137

Acid Dissociation Constant (pKa)

11.20

Base Dissociation Constant (pKb)

7.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

G069-0002 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G069-0002 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G069-0002?
Check Price and Availability of G069-0002, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G069-0002 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G069-0002
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G069-0002
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G069-0002 available by request